re: mopom Could be.....BUT I haven't seen any evidence thus far which would point a large buyer like himself to be trying to get them at these prices. Maybe soon though - who knows.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025